Platinum Priority – EditorialReferring to the article published on pp. 419–425 of this issueShould Prebiopsy Multiparametric Magnetic Resonance Imaging be Offered to All Biopsy-naïve Men Undergoing Prostate Biopsy?
Referring to the article published on pp. 419–425 of this issue
Section snippets
Conflicts of interest
The authors have nothing to disclose.
References (12)
- et al.
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013
Eur Urol
(2014) - et al.
Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies
J Urol
(2013) - et al.
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen
Eur Urol
(2014) - et al.
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies
Eur Urol
(2014) - et al.
Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial
Eur Urol
(2016) - et al.
Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion–targeted prostate biopsy outcomes
Eur Urol
(2016)
There are more references available in the full text version of this article.
Cited by (6)
Developing an effective strategy to improve the detection of significant prostate cancer by combining the 4Kscore and multiparametric MRI
2019, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :The drive to develop selective biopsy strategies that minimize the over detection of indolent prostate cancer have led to growing interest in ancillary or “reflex” tests such as the 4Kscore. Although mp-MRI is appealing because of its ability to characterize aggressive disease [5], there is no consensus on how it can be successfully integrated into the diagnostic paradigm in men undergoing PSA screening [6]. Despite a growing number of biomarkers and increasing use of mp-MRI prior to biopsy, there has been scant attention paid to developing a practical strategy for combining blood assays with mp-MRI in a way that would be feasible at a population level.
The role of tumor oxygenation tested by magnetic resonance imaging (MRI) in prostate cancer grading
2019, Medical Science MonitorDiagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
2018, Medicine (United States)What medical, urologic, and radiation oncologists want from molecular imaging of prostate cancer
2016, Journal of Nuclear Medicine
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.